The Diagnosis and Treatment of Respiratory Infections in Autoimmune Disease, Excluding Tuberculosis

作者: Graham H. Bothamley , Penny Shaw

DOI: 10.1007/978-3-0348-8926-1_5

关键词:

摘要: Respiratory infections play an important role in the morbidity and mortality associated with autoimmune disease. A patient disease who presents a fever, cough breathlessness or pleuritic pain may have respiratory infection, but these symptoms can also occur if there is exacerbation of process adverse reaction to medication. general approach such outlined as algorithm Figure 1. complete drug history essential. Empirical treatment antibiotics for common (e.g. penicillin macrolide), while awaiting results blood cultures, sputum examination serology, will cover majority episodes. Patients low numbers circulating neutrophils lymphocytes require special consideration. High-resolution computed tomography (CT) reveal parenchymal lesions where chest radiograph appears normal, ground-glass shadowing Pneumocystis carinii pneumonia (PCP), nodules Aspergillus early reaction, be diagnostic, e.g. “halo sign” infection. more invasive dictated by lack response treatment, again CT valuable planning procedure anatomical site sampled. The choice bronchoscopy, thoracoscopy open-lung biopsy determined patient’s condition: rapid worsening clinical state hypoxia recommend biopsy. Transbronchial biopsies are frequently too small provide adequate material make diagnosis, greater risk approaching failure from pneumothorax haemorrhage.

参考文章(88)
Oen K, Fast M, Postl B, Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975-92: cycles in incidence. The Journal of Rheumatology. ,vol. 22, pp. 745- 750 ,(1995)
M. Nouza, Pneumocystis carinii pneumonia after 40 years. Infection. ,vol. 20, pp. 113- 117 ,(1992) , 10.1007/BF01704594
Kimberly Rp, Ritchlin C, Christian Cl, Porges Aj, Beattie Sl, Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. The Journal of Rheumatology. ,vol. 19, pp. 1191- 1194 ,(1992)
Jarrousse B, Guillevin L, Leclerc P, Bindi P, Gilson B, Nilson B, Hachulla E, Rossert J, Rémy P, Jacquot C, Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clinical and Experimental Rheumatology. ,vol. 11, pp. 615- 621 ,(1993)
V Coutant-Perronne, L Guillevin, J C Piette, G Rostoker, B Godeau, S Dellion, G Magadur, M De Bandt, J Rossert, D Le Thi Huong, Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. The Journal of Rheumatology. ,vol. 21, pp. 246- 251 ,(1994)
Ohosone Y, Irimajiri S, Matsuoka Y, Suzuki A, Fukuda J, Mita S, Obana M, Cause of death in 81 autopsied patients with rheumatoid arthritis. The Journal of Rheumatology. ,vol. 21, pp. 33- 36 ,(1994)
Twohig Kj, Matthay Ra, Pulmonary effects of cytotoxic agents other than bleomycin. Clinics in Chest Medicine. ,vol. 11, pp. 31- 54 ,(1990)
Isenberg Da, Conroy Se, Latchman Ds, Tucker L, Incidence of anti Hsp 90 and 70 antibodies in children with SLE, juvenile dermatomyositis and juvenile chronic arthritis. Clinical and Experimental Rheumatology. ,vol. 14, pp. 99- 104 ,(1996)
A Jordan, R E Cowan, Reversible pulmonary disease and eosinophilia associated with sulphasalazine. Journal of the Royal Society of Medicine. ,vol. 81, pp. 233- 235 ,(1988) , 10.1177/014107688808100418